Anfield Capital Management’s Medtronic MDT Stock Holding History

Anfield Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.85K	Sell	56 -230	-80%	-$22K	﹤0.01%	510
2025 Q4	$27.5K	Buy	286 +230	+411%	+$22.3K	0.01%	235
2025 Q3	$5.33K	Hold	56	–	–	﹤0.01%	401
2025 Q2	$4.88K	Hold	56	–	–	﹤0.01%	370
2025 Q1	$5.03K	Sell	56 -56	-50%	-$5.01K	﹤0.01%	324
2024 Q4	$8.95K	Sell	112 -49	-30%	-$4.24K	﹤0.01%	249
2024 Q3	$14.5K	Buy	161 +105	+188%	+$8.83K	0.01%	195
2024 Q2	$4.41K	Hold	56	–	–	﹤0.01%	275
2024 Q1	$4.88K	Buy	+56	New	+$4.78K	﹤0.01%	207
2021 Q3	–	Sell	-128	Closed	-$16K	–	201
2021 Q2	$16K	Buy	+128	New	+$16.1K	0.01%	149
2020 Q3	–	Sell	-4,734	Closed	-$457K	–	90
2020 Q2	$457K	Buy	4,734 +103	+2%	+$9.88K	0.18%	73
2020 Q1	$418K	Buy	+4,631	New	+$493K	0.24%	75

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Anfield Capital Management's MDT Position: Q1 2026 in Review

Anfield Capital Management reduced its Medtronic (MDT) stake by 80% in Q1 2026, selling an estimated $22K and leaving 56 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

Anfield Capital Management first reported a position in MDT in Q1 2020 and has held it in 12 quarters since. The position peaked at $457K in Q2 2020. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Anfield Capital Management held 56 shares of Medtronic worth $4.85K as of Q1 2026.
Anfield Capital Management sold 230 Medtronic shares in Q1 2026, an estimated $22K.
Medtronic made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #510 holding.
Anfield Capital Management first reported a position in Medtronic in Q1 2020 and has held it in 12 quarters since.
Anfield Capital Management's Medtronic position peaked at $457K in Q2 2020.
2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.